Clovis Oncology
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, with additional office locations in the U.S. and Europe.
Show More
CEO
Patrick Mahaffy
Employees
429
Country
United States
ISIN
US1894641000
WKN
000A1JPJY
Listings
0 Comments
Share your thoughts
FAQs
What is Clovis Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Clovis Oncology stocks are traded under the ticker C6O.STU.
How many employees does Clovis Oncology have?▼
As of November 2, 2026, the company has 429 employees.
In which sector is Clovis Oncology located?▼
Clovis Oncology operates in the Manufacturing sector.
When did Clovis Oncology complete a stock split?▼
Clovis Oncology has not had any recent stock splits.
Where is Clovis Oncology headquartered?▼
Clovis Oncology is headquartered in Boulder, United States.